Home Small Caps

Small Caps

Latest

Here’s What Just Happened At Allergan

ME Staff - April 30, 2018

Bellicum Pharmaceuticals: Here’s What Just Happened And Why it Matters

Here’s What’s Moving Antares Pharma And Amgen This Week

Here’s Why Rigel Pharmaceuticals And Bio-Path Holdings Are Moving This Week

Edge Therapeutics And Apricus Biosciences Are Moving: Here’s Why

Here’s What’s Moving Bellicum Pharmaceuticals And Achaogen

ME Contributor - January 31, 2018

Cerus, Pfizer Both Just Put Out Key Late Stage Data

ME Contributor - January 25, 2018

Here’s What’s Moving Amarin Corporation and Puma Biotechnology

ME Contributor - January 24, 2018

Here Are Two Different Exposures To EV Industry Expansion That Nobody...

ME Contributor - January 22, 2018

These Two Biotechs Just Reported Key Data

ME Contributor - January 19, 2018

Here’s What Just Happened With Revance Therapeutics Inc (NASDAQ: RVNC) and...

ME Contributor - January 9, 2018

Celgene Corporation (NASDAQ:CELG) Kicks Off J.P. Morgan With A Bang

ME Contributor - January 8, 2018

A Deep Dive Into The Roche Holdings AG Basel ADR Common...

ME Contributor - January 5, 2018

Two Companies To Watch This Week: Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) And...

ME Contributor - January 3, 2018

Here’s What’s Moving Galena Biopharma, Inc. (NASDAQ:GALE) and Progenics Pharmaceuticals, Inc....

ME Contributor - January 2, 2018

123...91 Page 2 of 91

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Market Morning: Alexa Spying, Boeing Sensor History, Macron Spoils Scallop Dinner

April 11, 2019

ICC, AgraFlora to Bring Native Colombian Cannabis Strains to 39K Retail...

April 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.